James R Coats

Title: Innovations of James R Coats

Introduction

James R Coats is an accomplished inventor based in Oak Harbor, WA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of sodium channel inhibitors. With a total of 2 patents to his name, Coats has focused on creating compounds that address pain disorders through innovative mechanisms.

Latest Patents

Coats' latest patents include "Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors." This invention provides compounds that are inhibitors of voltage-gated sodium channels, specifically Nav 1.7. These compounds are designed for the treatment of diseases that can be managed by inhibiting sodium channels, such as pain disorders. Additionally, he has developed "Bicyclic aryl and heteroaryl sodium channel inhibitors," which also target Nav 1.7 and are useful for similar therapeutic applications.

Career Highlights

James R Coats is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions in the pharmaceutical industry. Coats' expertise in sodium channel inhibitors has positioned him as a key contributor to advancements in pain management therapies.

Collaborations

Coats has collaborated with notable colleagues, including Christiane Boezio and Howard Bregman. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

James R Coats is a prominent inventor whose work in sodium channel inhibitors has the potential to transform pain management therapies. His contributions to the field are marked by innovative patents and collaborations with esteemed colleagues.